000307372 001__ 307372
000307372 005__ 20251223120206.0
000307372 0247_ $$2doi$$a10.1016/j.eururo.2025.12.002
000307372 0247_ $$2pmid$$apmid:41419391
000307372 0247_ $$2ISSN$$a0302-2838
000307372 0247_ $$2ISSN$$a1421-993X
000307372 0247_ $$2ISSN$$a1873-7560
000307372 037__ $$aDKFZ-2025-03016
000307372 041__ $$aEnglish
000307372 082__ $$a610
000307372 1001_ $$0P:(DE-He78)7145565e57f6d4223f49daba4dd8cc96$$aCarlsson, Sigrid$$b0$$eFirst author$$udkfz
000307372 245__ $$aRisk-adapted Prostate Cancer Screening Achieves Mammography-like Benefits: Evidence and Implications for Europe.
000307372 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2025
000307372 3367_ $$2DRIVER$$aarticle
000307372 3367_ $$2DataCite$$aOutput Types/Journal article
000307372 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1766407933_3634864$$xEditorial
000307372 3367_ $$2BibTeX$$aARTICLE
000307372 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000307372 3367_ $$00$$2EndNote$$aJournal Article
000307372 500__ $$a#EA:C070#LA:C130# / epub
000307372 520__ $$aUsing Germany as a case example, a comparison between organized mammography screening and contemporary, risk-adapted screening for prostate cancer suggests that prostate-specific antigen-based early detection with incorporation of magnetic resonance imaging and active surveillance can achieve benefits comparable to those of mammography while addressing previous concerns about overdiagnosis and overtreatment. Findings from the PROBASE trial support the potential of such an approach to provide a favorable balance between benefit and harm when initiated at younger ages.
000307372 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000307372 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000307372 7001_ $$0P:(DE-He78)78a9df7108a5b079145be1cb1ab6a315$$aKrilaviciute, Agne$$b1$$udkfz
000307372 7001_ $$0P:(DE-He78)555d0aa06e51f29f46d788ff54fc6811$$aAl-Monajjed, Rouvier$$b2$$udkfz
000307372 7001_ $$0P:(DE-He78)fd17a8dbf8d08ea5bb656dfef7398215$$aSeibold, Petra$$b3$$udkfz
000307372 7001_ $$aKuczyk, Markus$$b4
000307372 7001_ $$aGschwend, Jürgen E$$b5
000307372 7001_ $$aDebus, Jürgen$$b6
000307372 7001_ $$aAntoch, Gerald$$b7
000307372 7001_ $$aSchimmöller, Lars$$b8
000307372 7001_ $$0P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec$$aSchlemmer, Heinz-Peter$$b9$$udkfz
000307372 7001_ $$aKristiansen, Glen$$b10
000307372 7001_ $$0P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aKaaks, Rudolf$$b11$$udkfz
000307372 7001_ $$0P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab$$aBecker, Nikolaus$$b12$$udkfz
000307372 7001_ $$0P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aAlbers, Peter$$b13$$udkfz
000307372 7001_ $$aGroup, PROBASE Study$$b14$$eCollaboration Author
000307372 773__ $$0PERI:(DE-600)1482253-2$$a10.1016/j.eururo.2025.12.002$$gp. S0302283825048559$$pnn$$tEuropean urology$$vnn$$x0302-2838$$y2025
000307372 909CO $$ooai:inrepo02.dkfz.de:307372$$pVDB
000307372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7145565e57f6d4223f49daba4dd8cc96$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000307372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)78a9df7108a5b079145be1cb1ab6a315$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000307372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)555d0aa06e51f29f46d788ff54fc6811$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000307372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fd17a8dbf8d08ea5bb656dfef7398215$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000307372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3d04c8fee58c9ab71f62ff80d06b6fec$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000307372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000307372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000307372 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000307372 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000307372 9141_ $$y2025
000307372 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2024-12-20$$wger
000307372 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR UROL : 2022$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-20
000307372 915__ $$0StatID:(DE-HGF)9920$$2StatID$$aIF >= 20$$bEUR UROL : 2022$$d2024-12-20
000307372 9202_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x0
000307372 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie der Krebsfrüherkennung$$x0
000307372 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie der Krebsfrüherkennung$$x0
000307372 9201_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x1
000307372 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x2
000307372 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebs$$x3
000307372 980__ $$ajournal
000307372 980__ $$aVDB
000307372 980__ $$aI:(DE-He78)C070-20160331
000307372 980__ $$aI:(DE-He78)C130-20160331
000307372 980__ $$aI:(DE-He78)E010-20160331
000307372 980__ $$aI:(DE-He78)C020-20160331
000307372 980__ $$aUNRESTRICTED